555 (Carbamazepine Extended-Release 100 mg)
Pill with imprint 555 is White, Round and has been identified as Carbamazepine Extended-Release 100 mg. It is supplied by Zydus Pharmaceuticals (USA) Inc..
Carbamazepine is used in the treatment of trigeminal neuralgia; bipolar disorder; schizoaffective disorder; epilepsy and belongs to the drug class dibenzazepine anticonvulsants. There is positive evidence of human fetal risk during pregnancy. Carbamazepine 100 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for 555
- 100 mg
- Prescription only
- Drug Class
- Dibenzazepine anticonvulsants
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Zydus Pharmaceuticals (USA) Inc.
- Cadila Healthcare Limited
- National Drug Code (NDC)
Related Images for "555"
More about carbamazepine
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Patient Tips
- Drug Images
- Drug Interactions
- Compare Alternatives
- Support Group
- Pricing & Coupons
- En Español
- 276 Reviews
- Drug class: dibenzazepine anticonvulsants
- FDA Alerts (2)
- Carbamazepine Chewable Tablets
- Carbamazepine Extended-Release Tablets
- Carbamazepine Extended-Release Capsules (Carbatrol)
- Carbamazepine Extended-Release Capsules (Equetro)
- ... +4 more
Related treatment guides
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.